InsidersTradesSigma
씨어스 Stock: price and directors' dealings · South Korea · DART (FSS)
Follow the 씨어스 stock price and the full management transaction log of the company, a listed equity based in South Korea. Shares are quoted on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 씨어스 has published 14 public disclosures. Market capitalisation: €1,122.8bn. The latest transaction was reported on 1 April 2026 (Purchase). Among the most active insiders: 윈베스트벤처투자. The full history is accessible without an account.
14
Insider Decl.
0
Thresholds
·
10 ops.
Buy Volume
·
2 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate 씨어스 Strong Buy (bullish), based on 3 analysts. Average price target: ₩69,000.
22Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 5,831 of 26,212 companies
65.6
score / 100
Value39
Quality92
FCF yld0.0%
Earn yld1.2%
EV/EBITDA·
ROE80%
Gross mgn72%
Net mgn33%
Debt/EBITDA0.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 1 April 2026
Declarations14 total
32,408 sharesKRXDART:20240924000325
671,550 sharesKRXDART:20240625000463
Ideal exit: 16 Mar 2025 (T+270)
14 of 14 declarations